Plasma hemoglobin and the risk of death in HIV/AIDS patients treated with antiretroviral therapy

Plasma hemoglobin and the risk of death in HIV/AIDS patients treated with antiretroviral therapy

Background: Previous studies concerning the effect of plasma hemoglobin (HB) and other factors that may modify the risk of death in people living with HIV/AIDS (PLHIV) treated with antiretroviral therapy (ART) are limited. Results: Higher HB was independently linked to a lower death risk in PLHIV, w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Aging (Albany, NY.) NY.), 2021-05, Vol.13 (9), p.13061-13072
Hauptverfasser: Wang, Dayong, Hou, Xiangqing, Yu, Xianghua, Wang, Tao, Ye, Zhenmiao, Li, Jushuang, Su, Feifei, Guo, Chengnan, Peng, Fang, Zhao, Shuzhen, Li, Huihui, Zuo, Jingjing, Su, Dehua, Zhao, Lina, Zhang, Hemei, Chen, Xiangyang, Wang, Ruoqiu, Xie, Qipeng, Zheng, Chao, Mao, Guangyun
Format: Artikel
Sprache:eng
Schlagworte:
Cell Biology
Geriatrics & Gerontology
Life Sciences & Biomedicine
Research Paper
Science & Technology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Previous studies concerning the effect of plasma hemoglobin (HB) and other factors that may modify the risk of death in people living with HIV/AIDS (PLHIV) treated with antiretroviral therapy (ART) are limited. Results: Higher HB was independently linked to a lower death risk in PLHIV, with a decrease of 29% (13%, 43%) per standard deviation (SD) increment after adjusting for CD4, VL and other potential factors [hazard ratio (HR): 0.71, 95% confidence interval (CI): 0.57-0.87, P
ISSN:1945-4589
1945-4589
DOI:10.18632/aging.202987